Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
HHV-8病毒干扰素调节因子1调控线粒体自噬的机制和功能
基本信息
- 批准号:10158457
- 负责人:
- 金额:$ 37.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS related cancerAcquired Immunodeficiency SyndromeAffectAntiviral AgentsAntiviral ResponseApoptosisAutophagocytosisBindingBiologicalBiologyCASP5 geneCaspaseCellsCharacteristicsChemicalsCommon NeoplasmDataDevelopmentDiseaseEnzymesEtiologyExcisionFamilyFutureGoalsHIVHuman Herpesvirus 8ImpairmentIndividualInfectionInterferonsKaposi SarcomaKnock-outLeadLinkLymphoma cellLyticMapsMediatingMitochondriaMolecularMulticentric Angiofollicular Lymphoid HyperplasiaMutateNatural ImmunityOncogenic VirusesOrgan TransplantationPathogenesisPathway interactionsPeptidesPharmacologyPlayPolyubiquitinationPost-Translational Modification SitePost-Translational Protein ProcessingProcessProteinsPublishingReagentRecombinantsRefractoryRegulationResearchRoleTechniquesTherapeuticTimeVariantViralViral Load resultVirusVirus DiseasesVirus Replicationacquired immunodeficiencyantiretroviral therapybaseinhibition of autophagyinsightlytic replicationnovelnovel strategiesprimary effusion lymphomareceptortargeted agentviral interferon regulatory factor-1virus host interaction
项目摘要
ABSTRACT
Human herpesvirus 8 (HHV-8) is a causal agent for Kaposi’s sarcoma, primary effusion lymphoma (PEL), and
multicentric Castleman’s disease that are often associated with acquired immunodeficiency syndrome. HHV-8
lytic replication, in addition to latency, is important for maintaining viral load within the host as well as for related
pathogenesis. Recent evidence shows that HHV-8-encoded viral interferon regulatory factor 1 (vIRF-1) plays an
important role in promoting virus replication by suppressing apoptosis and innate immunity elicited by infection of
host cells. We recently found, for the first time, that vIRF-1 localizes to mitochondria via a novel mechanism upon
virus replication and mitochondria-localized vIRF-1 is essential for successful virus replication. However, the
functional significance of mitochondria-localized vIRF-1 to HHV-8 biology and pathogenesis remains to be
determined. Our preliminary results showed that mitochondrial content is reduced in lytic vIRF-1-positive PEL
cells but restored by pharmacological inhibition of autophagy and mitophagy. Moreover, using recombinant HHV-
8 encoding vIRF-1 with impaired mitochondria targeting and a vIRF-1-derived peptide corresponding to the
mitochondrial targeting region, we demonstrated that mitochondria targeting of vIRF-1 plays an important role in
regulation of mitochondria content and apoptosis during HHV-8 replication. Our further studies revealed that vIRF-
1 interacts with autophagy-related proteins (GEC1 and EF-Tu) and is subject to posttranslational modifications
(caspase-5-mediated cleavage and K63-linked polyubiquitination) upon HHV-8 replication and mitochondrial
damage. Moreover, inhibition of mitophagy by Mdivi-1 enhances MAVS-mediated apoptosis induced by virus
replication and inhibits HHV-8 productive replication. Based on these findings, we hypothesize that vIRF-1 can
sense and respond to mitochondria damage induced by HHV-8 replication and promote removal of dysfunctional
mitochondria by activating mitophagy, resulting in inhibition of mitochondria-mediated antiviral responses and
promotion of HHV-8 replication. Therefore, an approach to interfere with vIRF-1-activated mitophagy could lead to
the development of novel antiviral agents. To further define the mechanisms and functional significance of vIRF-1-
activated mitophagy in HHV-8 replication, we propose to: 1) delineate the molecular mechanism(s) of vIRF-1-
mediated mitophagy activated by HHV-8 replication, 2) determine the significance to mitophagy regulation of
novel posttranslational modifications of mitochondria-localized vIRF-1, and 3) determine the functional
significance of vIRF-1-activated mitophagy in MAVS regulation and HHV-8 biology. Successful completion of the
studies in this application will delineate the molecular interactions and processes involved in vIRF-1-acitvated
mitophagy and provide evidence for the antiviral and therapeutic potentials of mitophagy inhibition. Overall, this
proposal will identify a novel paradigm of virus-host interaction via mitochondria and could potentially provide a
basis for future development of antiviral agents targeting mitophagy-associated interactions of vIRF-1.
摘要
人类疱疹病毒8(HHV-8)是卡波西肉瘤、原发性渗出性淋巴瘤(PEL)和
多中心Castleman病通常与获得性免疫缺陷综合征有关。HHV-8
除了潜伏期外,裂解性复制对于维持宿主内的病毒载量以及相关的免疫应答也是重要的。
发病机制最近的证据表明,HHV-8编码的病毒干扰素调节因子1(vIRF-1)在HHV-8感染中起重要作用。
在通过抑制细胞凋亡和由感染引起的先天性免疫来促进病毒复制中的重要作用
宿主细胞我们最近首次发现,vIRF-1通过一种新的机制定位于线粒体,
病毒复制和位于大肠杆菌中的vIRF-1对于成功的病毒复制至关重要。但
HHV-8生物学和发病机制中的VIRF-1的功能意义仍有待进一步研究。
测定我们的初步结果表明,在裂解性vIRF-1阳性的PEL中,
细胞,但通过药理学抑制自噬和线粒体自噬恢复。此外,使用重组HHV-
8编码线粒体靶向受损的vIRF-1和对应于该蛋白的vIRF-1衍生肽。
线粒体靶向区域,我们证明了线粒体靶向vIRF-1在
HHV-8复制过程中线粒体含量和细胞凋亡的调节。我们的进一步研究表明,vIRF-
1与自噬相关蛋白(GEC 1和EF-Tu)相互作用,并进行翻译后修饰
(caspase-5介导的切割和K63连接的多聚泛素化)对HHV-8复制和线粒体
损害此外,Mdivi-1对线粒体自噬的抑制增强了病毒诱导的MAVS介导的细胞凋亡。
复制并抑制HHV-8生产性复制。基于这些发现,我们假设vIRF-1可以
对HHV-8复制诱导的线粒体损伤进行感知和应答,并促进功能失调的
通过激活线粒体自噬,抑制线粒体介导的抗病毒反应,
促进HHV-8复制。因此,干扰vIRF-1激活的线粒体自噬的方法可能导致
新型抗病毒剂的开发。为了进一步阐明vIRF-1的作用机制和功能意义,
在HHV-8复制中激活的线粒体自噬,我们提出:1)描述vIRF-1的分子机制,
HHV-8复制激活的介导的线粒体自噬,2)确定
新的翻译后修饰的vIRF-1,和3)确定的功能
vIRF-1激活线粒体自噬在MAVS调节和HHV-8生物学中的意义。成功完成
本申请中的研究将描述vIRF-1激活的
并为线粒体自噬抑制的抗病毒和治疗潜力提供证据。总体而言,这
该提案将确定一种通过线粒体进行病毒-宿主相互作用的新模式,并可能提供一种
为将来开发靶向vIRF-1的线粒体自噬相关相互作用的抗病毒剂奠定了基础。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Herpesvirus Regulation of Selective Autophagy.
- DOI:10.3390/v13050820
- 发表时间:2021-05-01
- 期刊:
- 影响因子:0
- 作者:Vo MT;Choi YB
- 通讯作者:Choi YB
Herpesvirus lytic infection-induced mitophagy via viral interferon regulatory factor 1.
疱疹病毒裂解感染通过病毒干扰素调节因子 1 诱导线粒体自噬。
- DOI:10.1080/27694127.2023.2281135
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Vo,MaiTram;Choi,YoungBong
- 通讯作者:Choi,YoungBong
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Young Bong Choi其他文献
Young Bong Choi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Young Bong Choi', 18)}}的其他基金
Mitochondrial DRM targeting by HHV-8 viral interferon regulatory factor-1
HHV-8 病毒干扰素调节因子 1 靶向线粒体 DRM
- 批准号:
8582219 - 财政年份:2013
- 资助金额:
$ 37.46万 - 项目类别:
Mitochondrial DRM targeting by HHV-8 viral interferon regulatory factor-1
HHV-8 病毒干扰素调节因子 1 靶向线粒体 DRM
- 批准号:
8660616 - 财政年份:2013
- 资助金额:
$ 37.46万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 37.46万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 37.46万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 37.46万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 37.46万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 37.46万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 37.46万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 37.46万 - 项目类别: